248 related articles for article (PubMed ID: 16445569)
1. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
Ye J; Li A; Liu Q; Wang X; Zhou J
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1042-8. PubMed ID: 16445569
[TBL] [Abstract][Full Text] [Related]
2. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
3. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases.
Park JH; Kim EJ; Jang HY; Shim H; Lee KK; Jo HJ; Kim HJ; Yang SH; Jeong ET; Kim HR
Oncol Rep; 2008 Aug; 20(2):379-84. PubMed ID: 18636201
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
Iwama K; Nakajo S; Aiuchi T; Nakaya K
Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
Fukazawa H; Noguchi K; Murakami Y; Uehara Y
Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
[TBL] [Abstract][Full Text] [Related]
8. Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity.
Huang HS; Liu ZM; Ding L; Chang WC; Hsu PY; Wang SH; Chi CC; Chuang CH
J Biomed Sci; 2006 Jan; 13(1):113-25. PubMed ID: 16283431
[TBL] [Abstract][Full Text] [Related]
9. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
10. MEK inhibition enhances paclitaxel-induced tumor apoptosis.
MacKeigan JP; Collins TS; Ting JP
J Biol Chem; 2000 Dec; 275(50):38953-6. PubMed ID: 11038347
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects.
Baj G; Arnulfo A; Deaglio S; Mallone R; Vigone A; De Cesaris MG; Surico N; Malavasi F; Ferrero E
Breast Cancer Res Treat; 2002 May; 73(1):61-73. PubMed ID: 12083632
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.
Lunghi P; Tabilio A; Lo-Coco F; Pelicci PG; Bonati A
Leukemia; 2005 Feb; 19(2):234-44. PubMed ID: 15538402
[TBL] [Abstract][Full Text] [Related]
14. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
15. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK
Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae.
Wu JH; Hong LC; Tsai YY; Chen HW; Chen WX; Wu TS
Cell Microbiol; 2006 Sep; 8(9):1467-74. PubMed ID: 16922865
[TBL] [Abstract][Full Text] [Related]
18. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
19. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
